Joyce M. Slingerland

Author

Also Known As

J M Slingerland, J Slingerland, J. M. Slingerland, J. Slingerland, J. Slingerland, MD, FRCPC, PhD, Joyce M Slingerland, Joyce M. Slingerland, Joyce Slingerland, Slingerland, Joyce, Slingerland, Joyce M.

213

Publications

19K

Citations

H-Index

113

Concepts

All Affiliations

University of Miami Sylvester Comprehensive Cancer Center Sunnybrook Health Science Centre University of Toronto Health Sciences Centre

About

Joyce M. Slingerland is an author at University of Miami specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	49	10.7K
2	Health Sciences	10	10	1.1K
3	Natural Sciences	5	5	421
4	Education	1	1	34
5	Engineering	1	1	287

Joyce M. Slingerland

Publications

14.1K

Citations

H-Index

Page 1

	Year	Citations
New functional activities for the p21 family of CDK inhibitors. Joshua LaBaer, Michelle D. Garrett, Lauren Stevenson, Genes & Development Functional Kinase ComplexesImmunologyCell CycleComplex AssemblyMolecular Pharmacology	1997	1.4K
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Jiyong Liang, Judit Zubovitz, Teresa Petrocelli, Nature Medicine Tumor BiologyMolecular PhysiologySignal TransductionSignaling PathwayCell Regulation	2002	941
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression Jiyong Liang, Joyce M. Slingerland Cell Cycle Cell DeathG2/m TransitionCell CycleTumor BiologySignaling Pathway	2003	880
The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis Jiyong Liang, Shan Shao, Zhixiang Xu, Nature Cell Biology Cell AutophagyMitophagyMolecular PhysiologySignal TransductionSignaling Pathway	2007	846
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer Charles Catzavelos, Nandita Bhattacharya, Yee Ung, Nature Medicine Breast OncologyMedicinePrimary Breast CancerBreast CancerPrognostic Implications	1997	843
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways Mirjam C. Boelens, Tony J. Wu, Barzin Y. Nabet, Cell Breast OncologyExosomesMedicineCell TraffickingBreast Cancer Cells	2014	782
Skp2 is oncogenic and overexpressed in human cancers Matthias Gstaiger, Richard C. Jordan, Megan S. Lim, Proceedings of the National Academy of Sciences	2001	501
E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 Brad St. Croix, Capucine Sheehan, Janusz Rak, The Journal of Cell Biology	1998	447
p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 Isabel Chu, Jun Sun, Angel Arnaout, Cell Signal TransductionCell RegulationMolecular PathwayReceptor Tyrosine KinaseP27 Phosphorylation	2007	368
A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Joyce M. Slingerland, Ludger Hengst, Chen Pan, Molecular and Cellular Biology Cdk2 KinaseSystems BiologySignal TransductionNovel InhibitorCell Regulation	1994	325

Page 1